Insider Transactions in Q1 2025 at Chimerix Inc (CMRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2025
|
Allen S. Melemed CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,065
-1.97%
|
$12,260
$4.5 P/Share
|
|
Feb 13
2025
|
Michelle La Spaluto CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,260
-1.29%
|
$9,040
$4.51 P/Share
|
|
Feb 13
2025
|
David Jakeman VP OF FINANCE AND ACCOUNTING |
SELL
Open market or private sale
|
Direct |
300
-0.2%
|
$1,200
$4.53 P/Share
|
|
Feb 13
2025
|
Michael Albert Alrutz SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
1,600
-0.74%
|
$6,400
$4.52 P/Share
|
|
Feb 13
2025
|
Michael T. Andriole PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
7,370
-1.19%
|
$29,480
$4.52 P/Share
|
|
Jan 30
2025
|
David Jakeman VP OF FINANCE AND ACCOUNTING |
SELL
Open market or private sale
|
Direct |
2,800
-1.84%
|
$11,200
$4.1 P/Share
|
|
Jan 30
2025
|
Michael T. Andriole PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,350
-0.38%
|
$9,400
$4.1 P/Share
|
|
Jan 30
2025
|
Michelle La Spaluto CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,015
-0.58%
|
$4,060
$4.11 P/Share
|
|
Jan 07
2025
|
David Jakeman VP OF FINANCE AND ACCOUNTING |
BUY
Grant, award, or other acquisition
|
Direct |
10,855
+6.66%
|
-
|
|
Jan 07
2025
|
Allen S. Melemed CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
45,925
+22.75%
|
-
|
|
Jan 07
2025
|
Michelle La Spaluto CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
41,667
+19.12%
|
-
|
|
Jan 07
2025
|
Michael T. Andriole PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+19.5%
|
-
|
|
Jan 07
2025
|
Michael Albert Alrutz SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
41,667
+16.22%
|
-
|
|
Jan 07
2025
|
Thomas J Riga COO and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
54,275
+48.56%
|
-
|